Abstract | OBJECTIVE: METHODS: Serum neutrophil elastase and α₁-anti- trypsin concentrations were assessed in SSc patients and healthy controls by ELISA. Serum neutrophil elastase activity was assessed by the elastase-dependent conversion of methoxy-succinyl-alanyl-alanyl-prolyl-valyl-p-nitroanilide to p-nitroanilide using a colourimetric assay. Elastase concentration and activity were correlated with clinical disease features. RESULTS: Serum neutrophil elastase concentration and activity were equivalent in patients and controls; however, in SSc serum, there was an increase in elastase activity for each unit of elastase concentration (P = 0.03). This was due to a decrease in serum α₁-anti- trypsin concentrations (P = 0.04). Serum elastase concentration (P = 0.03) and activity (P = 0.02) were significantly lower in RNP-positive patients and serum elastase concentrations were lower in ANA-positive patients (P = 0.003). CONCLUSIONS: Relative deficiency in serum α₁-anti- trypsin concentrations in SSc could have important and pathogenically relevant effects since elastase has pro-inflammatory and pro-fibrotic roles. Elastase inhibitors are available in clinical practice and could represent potential therapeutic options in SSc.
|
Authors | Theresa C Barnes, Andy Cross, Marina E Anderson, Steven W Edwards, Robert J Moots |
Journal | Rheumatology (Oxford, England)
(Rheumatology (Oxford))
Vol. 50
Issue 8
Pg. 1373-8
(Aug 2011)
ISSN: 1462-0332 [Electronic] England |
PMID | 21454304
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- alpha 1-Antitrypsin
- Leukocyte Elastase
|
Topics |
- Cells, Cultured
- Humans
- Leukocyte Elastase
(blood)
- Neutrophils
(enzymology)
- Scleroderma, Systemic
(blood, complications)
- alpha 1-Antitrypsin
(blood)
- alpha 1-Antitrypsin Deficiency
(blood, complications)
|